Skip to main content
. 2020 Jul 1;2020:1894907. doi: 10.1155/2020/1894907

Table 1.

Summary of method development optimization.

Drug Mobile phase pH Diluent used
Buffer ACN
FAM and IND mixture 93 7 6 Diluent 1
93 7 5
50 50 5.5
60 40 5.5 & 6
40 60 5.5 & 5

Codrug 40 60 5 Diluent 1

PAR 40 60 5 Diluent 1
Methanol
ACN

FAM, codrug, and IND separately 40 60 5 ACN

Mixture of all drugs 40 60 5 ACN